Craig Ostroff

Conference Coverage

Decision Support Through Structured Data

10/14/2022

At the 2022 Oncology Clinical Pathways Congress, Mary M. Ichiuji, MD, Kaiser Permanente and National Physician Lead, Beacon Oncology, presented the development of Kaiser Permanente Beacon Oncology Module EPIC, a patient-centered,...

At the 2022 Oncology Clinical...

10/14/2022

Journal of Clinical Pathways

Conference Coverage

Updated, Longer-term Efficacy Data Following Subsequent Therapy in ICARIA-MM

12/10/2022

Craig Ostroff ;

Paul G Richardson, MD, and colleagues presented a study at the 64th ASH Annual Meeting and Exposition and discussed updated and longer-term efficacy data regarding multiple lines of therapy subsequent to ICARIA-MM.

Paul G Richardson, MD, and...

12/10/2022

Journal of Clinical Pathways

Conference Coverage

Complex Diagnostic Imaging and the CMS Imaging AUC Program

10/16/2022

Katie Herman ;

Craig Ostroff ;

Elliot K Fishman, MD, FACR, Professor of Radiology, Oncology, Surgery and Urology, Johns Hopkins Hospital, presented at the 2022 Oncology Clinical Pathways Congress about Medicare’s Appropriate Use Criteria program and the challenges in...

Elliot K Fishman, MD, FACR,...

10/16/2022

Journal of Clinical Pathways

Conference Coverage

ePROs Effect on Patient Health Outcomes

10/17/2022

Katie Herman ;

Craig Ostroff ;

Michael Kolodziej, MD, Senior Advisor, ADVI, presented that patient monitoring during treatment using electronic patient-reported outcomes significantly improves results.

Michael Kolodziej, MD, Senior...

10/17/2022

Journal of Clinical Pathways

Conference Coverage

A 12-Gene Signature Accurately Predicts Progression From Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma

12/10/2022

Craig Ostroff ;

Speaking at the 64th ASH Annual Meeting and Exposition, Fumou Sun, PhD, and colleagues discussed a 12-gene score that demonstrated noticeable accuracy in predicting 10-year progression to multiple myeloma in a limited population of patients...

Speaking at the 64th ASH Annual...

12/10/2022

Journal of Clinical Pathways

Conference Coverage

Integrating Social Determinants of Health

10/16/2022

Katie Herman ;

Craig Ostroff ;

At the 2022 Oncology Clinical Pathways Congress, Mishellene McKinney, MHA, RN, OCN, Vice President, Cancer Care Services, Kaiser Permanente; and Anand Shah, MD, MS, Vice President, Social Health, Kaiser Permanente, discussed the importance of...

At the 2022 Oncology Clinical...

10/16/2022

Journal of Clinical Pathways

Conference Coverage

CancerLinQ Technology in the Oncology Community

10/17/2022

Katie Herman ;

Craig Ostroff ;

Robert S. Miller, MD, FACP, FASCO, FAMIA, Chief Medical Science Officer, CancerLinQ, American Society of Clinical Oncology, described how data aggregation and analytic platforms are aiding in clinical decision support and explained current...

Robert S. Miller, MD, FACP,...

10/17/2022

Journal of Clinical Pathways

Conference Coverage

Real-world Outcomes of ASCT in Initial Therapy in Patients With Newly Diagnosed Multiple Myeloma

12/10/2022

Craig Ostroff ;

Julie Cote, MD, and colleagues discuss real-world outcomes of patients treated with autologous stem cell transplant as part of their initial multiple myeloma therapy during their presentation at the 64th ASH Annual Meeting and Exposition.

Julie Cote, MD, and colleagues...

12/10/2022

Journal of Clinical Pathways

Conference Coverage

Cancer Care Equity and Collaboration

10/16/2022

Katie Herman ;

Craig Ostroff ;

At the 2022 Oncology Clinical Pathways Congress, Lawrence N Shulman, MD, Abramson Cancer Center University of Pennsylvania, summarized the status of cancer care in the United States and proposed how collaborative care can enhance quality of...

At the 2022 Oncology Clinical...

10/16/2022

Journal of Clinical Pathways

Conference Coverage

Can Real-World Evidence Improve Clinical Pathways?

10/14/2022

Craig Ostroff ;

At the 2022 Oncology Clinical Pathway Congress, Rebecca Miksad, MD, MPH, Flatiron Health; and Carole Tremonti, RN, MBA, Three Mountains LLC, presented how population-level data provides specificity and creates value in aiding decision-making.

At the 2022 Oncology Clinical...

10/14/2022

Journal of Clinical Pathways